The availability of generic drugs is expected to have a positive impact in Canada, including potential cost savings for patients and the health-care system, the federal agency said in a news release Monday
But this year, the American Journal of Clinical Nutrition released dietary guidelines to consider when prescribing and using GLP-1s
The major adverse effects of GLP-1RAs are nausea and vomiting, which occur in approximately 70% of participants [13]
Cerebrovascular pathology, including atherosclerosis and microangiopathy, evolves insidiously over several decades [22]
In December, the FDA declared that Eli Lilly's weight loss and diabetes medication tirzepatide, sold under the brand names Mounjaro and Zepbound, was no longer in short supply